Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.19.1
Document and Entity Information - shares
9 Months Ended
Mar. 31, 2019
May 14, 2019
Document and Entity Information [Abstract]    
Entity Registrant Name DelMar Pharmaceuticals, Inc.  
Entity Central Index Key 0001498382  
Trading Symbol DMPI  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Document Type 10-Q  
Document Period End Date Mar. 31, 2019  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   2,652,038